+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Atherectomy Devices Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 140 Pages
  • January 2025
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 6050556
The atherectomy devices market is estimated to grow from US$1.18 billion in 2025 to US$1.68 billion by 2030, at a CAGR of 7.29%.

An atherectomy device is designed to remove plaque and other materials from atherosclerotic blood vessels. Various types of atherectomy procedures exist, including excisional atherectomy, laser ablation atherectomy, and rotational atherectomy. The global atherectomy device market is experiencing significant growth, primarily due to rapid advancements in medical technology. Recent developments have led to the introduction of safer and more efficient devices, which have contributed to the market's expansion. A key driver of this growth is the increasing demand for minimally invasive procedures. There has been a notable shift towards less invasive surgeries, which offer benefits such as reduced recovery times and lower complication rates. However, the high cost of equipment and procedures poses a challenge to market growth. Developing these devices involves substantial research expenses, which contribute to rising manufacturing costs. Additionally, while atherectomy devices can help dilate arteries, they may also lead to increased rates of restenosis, potentially affecting their long-term effectiveness.

Drivers of the Atherectomy Devices Market

  • Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular diseases globally is a significant factor driving the growth of the atherectomy device market. Conditions such as Peripheral Artery Disease (PAD) and Coronary Artery Disease (CAD) are becoming more common, and atherectomy devices are essential for restoring healthy blood flow and alleviating symptoms associated with these diseases. According to the American Heart Association, approximately 200 million people worldwide are affected by PAD, with around 12 million cases reported in the USA alone. The prevalence of PAD is particularly high among individuals over 70 years old.

Geographical Outlook

  • North America Expected to Dominate: North America is projected to hold a substantial share of the atherectomy devices market during the forecast period. The region is witnessing significant growth due to the rising cases of cardiovascular diseases, especially in the USA and Canada. Additionally, advancements in the healthcare sector are contributing to market expansion. The increasing prevalence of cardiovascular conditions in North America is further supported by favorable reimbursement policies and a robust healthcare infrastructure.
In summary, factors such as the growing prevalence of cardiovascular diseases and technological advancements are expected to drive growth in the atherectomy device market, particularly in North America.

Reasons for buying this report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence.

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Atherectomy Devices Market is segmented and analyzed as:

  • By Product Type
    • Directional Atherectomy Devices
    • Rotational Atherectomy Devices
    • Orbital Atherectomy Devices
    • Laser Atherectomy Devices
    • Photo-Ablative Atherectomy Devices
    • Others
  • By Application
    • Peripheral Vascular
    • Cardiovascular
    • Neurovascular
  • By End-User
    • Hospitals
    • Research Laboratories
    • Ambulatory Surgical Centers
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific Region
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Taiwan
      • Others

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. ATHERECTOMY DEVICES MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Directional Atherectomy Devices
5.3. Rotational Atherectomy Devices
5.4. Orbital Atherectomy Devices
5.5. Laser Atherectomy Devices
5.6. Photo-Ablative Atherectomy Devices
5.7. Others
6. ATHERECTOMY DEVICES MARKET BY APPLICATION
6.1. Introduction
6.2. Peripheral Vascular
6.3. Cardiovascular
6.4. Neurovascular
7. ATHERECTOMY DEVICES MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Research Laboratories
7.4. Ambulatory Surgical Centers
7.5. Others
8. ATHERECTOMY DEVICES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Product Type
8.3.2. By Application
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Product Type
8.4.2. By Application
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. France
8.4.4.3. United Kingdom
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Application
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. UAE
8.5.4.2. Saudi Arabia
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Product Type
8.6.2. By Application
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Taiwan
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Boston Scientific Corporation
10.2. BD (Becton, Dickinson, and Company)
10.3. Abbott
10.4. Koninklijke Philips N.V.
10.5. Medtronic
10.6. AngioDynamics
10.7. Biomerics
10.8. Avinger
10.9. Cardio Flow, Inc.
10.10. InspireMD, Inc
10.11. AMETEK Inc.

Companies Mentioned

  • Boston Scientific Corporation
  • BD (Becton, Dickinson, and Company)
  • Abbott
  • Koninklijke Philips N.V.
  • Medtronic
  • AngioDynamics
  • Biomerics
  • Avinger
  • Cardio Flow, Inc.
  • InspireMD, Inc
  • AMETEK Inc.

Methodology

Loading
LOADING...

Table Information